Key facts
- It has raised $2.8M; the latest was Seed Round ($560K) in Jan 2025.
- Notable investors include InnoEnergy, Seeds of Bravery, The Roddenberry Foundation, Allan Mink, Biomedical Zone — 21 tracked in total.
- Caretech Human has filed 1 Form D with the SEC, most recently Nov 2023 ($65K sold to 4 investors).
- Status: Privately Held (backing).
- ·The complete investor list — 21 names
- ·Watchlist + deal alerts for Caretech Human
- ·The full record, as it builds
Funding rounds
No funding rounds for Caretech Human are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Caretech Human
Manufacturer of a toilet-integrated remote patient health monitoring device designed to monitor lower urinary tract symptoms (LUTS) and detect early signs of urological diseases. The company offers a device for remote patient health monitoring that can detect the earliest signs of disease via urine analysis, the device is attached to a patient's home toilet and passively collects actionable data, offering a seamless user experience, it utilizes sensors and artificial intelligence to analyze urine and stool samples, providing users with real-time insights into their health, and to proactively manage their health and seek timely medical attention if necessary.
- Sector
- Healthcare
- HQ
- Ithaca, NY, United States
- Founded
- 2019
- Employees
- 15
- Website
- caretechhuman.com/
- Ownership
- Privately Held (backing)
Caretech Human doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Caretech Human shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Caretech Human in its N-PORT filings yet. We sweep new filings monthly.